Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086059 · ClinicalTrials.gov registry record
OTIS Humira Pregnancy Registry
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 944
- Enrollment target
NCT01086059 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 944 participants.
The verdict
NCT01086059 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 944 participants
- Enrollment target
Study Summary
The purpose of the OTIS Autoimmune disease in pregnancy study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects that are visible at birth, as well as, more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 944 participants |
| Start Date | 2003-11 |
| Est. Completion | 2019-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01086059
The ClinicalTrials.gov registry entry for NCT01086059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 944 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01086059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01086059 about?
NCT01086059 is a clinical study titled "OTIS Humira Pregnancy Registry". The purpose of the OTIS Autoimmune disease in pregnancy study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it i...
What is the current status of trial NCT01086059?
This trial is currently completed. The enrollment target is 944 participants. The study started on 2003-11. Estimated completion is 2019-10.
Who is sponsoring clinical trial NCT01086059?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.